Literature DB >> 27160072

Alterations to retinal architecture prior to photoreceptor loss in a mouse model of retinitis pigmentosa.

Sarah L Roche1, Alice C Wyse-Jackson, Ashleigh M Byrne, Ana M Ruiz-Lopez, Thomas G Cotter.   

Abstract

Mouse models of retinitis pigmentosa (RP) are essential tools in the pursuit to understand fully what cell types and processes underlie the degeneration observed in RP. Knowledge of these processes is required if we are to develop successful therapies to treat this currently incurable disease. We have used the rd10 mouse model of RP to study retinal morphology prior to photoreceptor loss, using immunohistochemistry and confocal microscopy on cryosections, since little is known about how the mutation affects the retina during this period. We report novel findings that the mutation in the rd10 mouse results in retinal abnormalities earlier than was previously thought. Defects in rod and cone outer segments, bipolar cells, amacrine cells and photoreceptor synapses were apparent in the retina during early stages of postnatal retinal development and prior to the loss of photoreceptors. Additionally, we observed a dramatic response of glial cells during this period. Microglia responded as early as postnatal day (P) 5; ?13 days before any photoreceptor loss is detected with Müller glia and astrocytes exhibiting changes from P10 and P15 respectively. Overall, these findings present pathological aspects to the postnatal development of the rd10 retina, contributing significantly to our understanding of disease onset and progression in the rd10 mouse and provide a valuable resource for the study of retinal dystrophies.

Entities:  

Mesh:

Year:  2016        PMID: 27160072     DOI: 10.1387/ijdb.150400tc

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  13 in total

1.  A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Authors:  Clayton P Santiago; Casey J Keuthan; Sanford L Boye; Shannon E Boye; Aisha A Imam; John D Ash
Journal:  Mol Ther       Date:  2018-07-19       Impact factor: 11.454

2.  Synaptic changes and the response of microglia in a light-induced photoreceptor degeneration model.

Authors:  Sisi Xu; Peijun Zhang; Meng Zhang; Xin Wang; Gang Li; Gezhi Xu; Yingqin Ni
Journal:  Mol Vis       Date:  2021-05-01       Impact factor: 2.367

3.  Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.

Authors:  Sarah L Roche; Alice C Wyse-Jackson; Violeta Gómez-Vicente; Pedro Lax; Ana M Ruiz-Lopez; Ashleigh M Byrne; Nicolás Cuenca; Thomas G Cotter
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

4.  The synthetic progestin norgestrel modulates Nrf2 signaling and acts as an antioxidant in a model of retinal degeneration.

Authors:  Ashleigh M Byrne; Ana M Ruiz-Lopez; Sarah L Roche; Jennifer N Moloney; Alice C Wyse-Jackson; Thomas G Cotter
Journal:  Redox Biol       Date:  2016-10-04       Impact factor: 11.799

5.  Early Microglia Activation Precedes Photoreceptor Degeneration in a Mouse Model of CNGB1-Linked Retinitis Pigmentosa.

Authors:  Thomas Blank; Tobias Goldmann; Mirja Koch; Lukas Amann; Christian Schön; Michael Bonin; Shengru Pang; Marco Prinz; Michael Burnet; Johanna E Wagner; Martin Biel; Stylianos Michalakis
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

6.  Early Events in Retinal Degeneration Caused by Rhodopsin Mutation or Pigment Epithelium Malfunction: Differences and Similarities.

Authors:  Johnny Di Pierdomenico; Diego García-Ayuso; Isabel Pinilla; Nicolás Cuenca; Manuel Vidal-Sanz; Marta Agudo-Barriuso; María P Villegas-Pérez
Journal:  Front Neuroanat       Date:  2017-03-06       Impact factor: 3.856

7.  Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina.

Authors:  Sarah L Roche; Alice C Wyse-Jackson; Ana M Ruiz-Lopez; Ashleigh M Byrne; Thomas G Cotter
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

8.  The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Filippo Locri; Valeria Pecci; Mario De Rosa; Vincenzo Pavone; Paola Bagnoli
Journal:  J Cell Mol Med       Date:  2019-06-28       Impact factor: 5.310

9.  Selective Histone Deacetylase 6 Inhibitors Restore Cone Photoreceptor Vision or Outer Segment Morphology in Zebrafish and Mouse Models of Retinal Blindness.

Authors:  Husvinee Sundaramurthi; Sarah L Roche; Guinevere L Grice; Ailis Moran; Eugene T Dillion; Giuseppe Campiani; James A Nathan; Breandán N Kennedy
Journal:  Front Cell Dev Biol       Date:  2020-08-26

10.  Gradual Increase in Environmental Light Intensity Induces Oxidative Stress and Inflammation and Accelerates Retinal Neurodegeneration.

Authors:  Oksana Kutsyr; Xavier Sánchez-Sáez; Natalia Martínez-Gil; Emilio de Juan; Pedro Lax; Victoria Maneu; Nicolás Cuenca
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.